Page 50 - Read Online

47. Martyn CN, Barker DJ, Osmond C, Harris EC, Edwardson JA, Parkinson’s disease and brain levels of organochlorine pesticides.
Lacey RF. Geographical relation between Alzheimer’s disease and Ann Neurol 1994;36:100‑3.
aluminum in drinking water. Lancet 1989;1:59‑62. 60. El‑Amouri SS, Zhu H, Yu J, Gage FH, Verma IM, Kindy MS.
48. Graves AB, White E, Koepsell TD, Reifler BV, van Belle G, Neprilysin protects neurons against Abeta peptide toxicity. Brain
Larson EB. The association between aluminum‑containing products Res 2007;1152:191‑200.
and Alzheimer’s disease. J Clin Epidemiol 1990;43:35‑44. 61. Albuquerque EX, Pereira EF, Aracava Y, Fawcett WP, Oliveira M,
49. Broe GA, Henderson AS, Creasey H, McCusker E, Korten AE, Randall WR, Hamilton TA, Kan RK, Romano JA Jr, Adler M.
Jorm AF, Longley W, Anthony JC. A case‑control study of Effective countermeasure against poisoning by organophosphorus
Alzheimer’s disease in Australia. Neurology 1990;40:1698‑707. insecticides and nerve agents. Proc Natl Acad Sci U S A
50. Foster HD. How aluminum causes Alzheimer’s disease: the 2006;103:13220‑5.
implications for prevention and treatment of Foster’s multiple 62. Lahiri DK, Maloney B. The “LEARn” (Latent Early‑life Associated
antagonist hypothesis. J Orthomol Med 2000;15:21‑51. Regulation) model integrates environmental risk factors and the
51. Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, developmental basis of Alzheimer’s disease, and proposes remedial
Markesbery WR. Copper, iron and zinc in Alzheimer’s disease steps. Exp Gerontol 2010;45:291‑6.
senile plaques. J Neurol Sci 1998;158:47‑52. 63. Fan LW, Tien LT, Lin RC, Simpson KL, Rhodes PG, Cai Z.
52. Molina JA, Jiménez‑Jiménez FJ, Aguilar MV, Meseguer I, Neonatal exposure to lipopolysaccharide enhances vulnerability
Mateos‑Vega CJ, González‑Muñoz MJ, de Bustos F, Porta J, of nigrostriatal dopaminergic neurons to rotenone neurotoxicity in
Ortí‑Pareja M, Zurdo M, Barrios E, Martínez‑Para MC. Cerebrospinal later life. Neurobiol Dis 2011;44:304‑16.
fluid levels of transition metals in patients with Alzheimer’s disease. 64. Zawia NH, Lahiri DK, Cardozo‑Pelaez F. Epigenetics, oxidative stress,
J Neural Transm 1998;105:479‑88. and Alzheimer disease. Free Radic Biol Med 2009;46:1241‑9.
53. Kowalik‑Jankowska T, Ruta‑Dolejsz M, Wisniewska K, Lankiewicz L, 65. Wu J, Basha MR, Zawia NH. The environment, epigenetics and
Kozlowski H. Possible involvement of copper (II) in Alzheimer amyloidogenesis. J Mol Neurosci 2008;34:1‑7.
disease. Environ Health Perspect 2002;110 Suppl 5:869‑70. 66. Stewart WF, Schwartz BS, Davatzikos C, Shen D, Liu D, Wu X,
54. Huang X, Moir RD, Tanzi RE, Bush AI, Rogers JT. Redox‑active Todd AC, Shi W, Bassett S, Youssem D. Past adult lead exposure
metals, oxidative stress, and Alzheimer’s disease pathology. Ann N is linked to neurodegeneration measured by brain MRI. Neurology
Y Acad Sci 2004;1012:153‑63. 2006;66:1476‑84.
55. Graves AB, Rosner D, Echeverria D, Mortimer JA, Larson EB. 67. Stewart WF, Schwartz BS, Simon D, Kelsey K, Todd AC. ApoE
Occupational exposures to solvents and aluminium and estimated genotype, past adult lead exposure, and neurobehavioral function.
risk of Alzheimer’s disease. Occup Environ Med 1998;55:627‑33. Environ Health Perspect 2002;110:501‑5.
56. Gun RT, Korten AE, Jorm AF, Henderson AS, Broe GA, Creasey H, 68. Basha MR, Wei W, Bakheet SA, Benitez N, Siddiqi HK, Ge YW,
McCusker E, Mylvaganam A. Occupational risk factors for Lahiri DK, Zawia NH. The fetal basis of amyloidogenesis: exposure
Alzheimer disease: a case‑control study. Alzheimer Dis Assoc Disord to lead and latent overexpression of amyloid precursor protein and
1997;11:21‑7. beta‑amyloid in the aging brain. J Neurosci 2005;25:823‑9.
57. Sobel E, Dunn M, Davanipour Z, Qian Z, Chui HC. Elevated risk
of Alzheimer’s disease among workers with likely electromagnetic Cite this article as: Yu J, Zhu H, Bhat A, El-Sayed H, Gudz T, Gattoni-
field exposure. Neurology 1996;47:1477‑81. Celli S, Kindy MS. Influence of chlorpyrifos oxon on the development and
58. Graves AB, Rosner D, Echeverria D, Yost M, Larson EB. progression of Alzheimer’s disease in amyloid precursor protein transgenic
mice. Neuroimmunol Neuroinflammation 2015;2(1):31-42.
Occupational exposure to electromagnetic fields and Alzheimer
disease. Alzheimer Dis Assoc Disord 1999;13:165‑70. Source of Support: Nil. Conflict of Interest: No.
59. Fleming L, Mann JB, Bean J, Briggle T, Sanchez‑Ramos JR. Received: 14-09-2014; Accepted: 21-10-2014

42 Neuroimmunol Neuroinflammation | Volume 2 | Issue 1 | January 15, 2015